Read the incredible story of a medical student's battle with sepsis and the urgent call for action against antimicrobial resistance. #SurvivingSepsis #HealthCrisis
Surviving sepsis is not just a medical triumph but also a wake-up call to the looming threat of antimicrobial resistance. Liv Dumville, a medical student, shares her harrowing experience and advocates for global awareness and action to combat this health crisis. The deadly consequences of sepsis with imbalanced pro- and anti-inflammatory cytokines highlight the importance of early detection and treatment to improve patient outcomes. The recent tragic deaths due to sepsis, particularly alarming in children, underscore the critical need for better management of the condition within healthcare systems. Sepsis remains a significant global challenge, with each avoidable death emphasizing the urgency for improved protocols and healthcare responses.
As we delve deeper into sepsis awareness, it becomes evident that early identification and proper treatment are vital in saving lives. Understanding the intricate balance of cytokines in sepsis can lead to more effective therapeutic interventions and improved patient survival rates. Moreover, the coroners' warnings following the avoidable deaths serve as a stark reminder of the critical importance of healthcare providers' vigilance in detecting and treating sepsis promptly. It is imperative that healthcare systems prioritize sepsis management to prevent unnecessary loss of lives and enhance patient outcomes.
After surviving sepsis, medical student Liv Dumville has a newfound appreciation of the need to address the global health threat of antimicrobial resistance ...
Patients with sepsis with high levels of pro-inflammatory and anti-inflammatory cytokines may have worse organ dysfunction and survival.
Preventable deaths of seven people from sepsis โ including four children โ have prompted coroners to flag major concerns about NHS services' management of ...
Inthelia Therapeutics, founded by two top Irish scientists, is switching focus to block infection getting a grip on patients in the first place.
A large international team led by Northwestern Medicine investigators has established new standardized diagnostic criteria for pediatric sepsis, ...
Research scientist Prof Steve Kerrigan and pharma entrepreneur Dr Ivan Coulter are the co-founders of Inthelia Therapeutics, a clinical stage ...